Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;17(5):719-726.
doi: 10.1038/s41557-024-01730-7. Epub 2025 Feb 20.

Catalytic difluorocarbene insertion enables access to fluorinated oxetane isosteres

Affiliations

Catalytic difluorocarbene insertion enables access to fluorinated oxetane isosteres

Tong-De Tan et al. Nat Chem. 2025 May.

Abstract

Skeletal editing of heterocyclic building blocks offers an appealing way to expand the accessible chemical space by diversifying molecular scaffolds for drug discovery. Despite the recent boom in this area, catalytic strategies that directly introduce fluorine into the backbone of small-ring heterocycles remain rare owing to the challenges of strain-induced ring cleavage and defluorination. Here we describe a copper-catalysed approach for skeletal expansion of oxygen heterocycles by reaction with a difluorocarbene species generated in situ to induce carbon atom insertion. The α,α-difluoro-oxetane products are potential surrogates of oxetane, β-lactone and carbonyl pharmacophores on the basis of their computed molecular properties and electrostatic potential maps. The utility of this approach is highlighted by synthesis of various drug-like molecules and fluorinated isosteres of biologically active compounds. Experimental and computational investigations provide insight into the mechanism and the unique role of the copper catalyst in promoting both ring-opening and cyclization steps of the reaction.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Hassner, A. Small Ring Heterocycles (Wiley-VCH, 1983).
    1. Rojas, J. J. & Bull, J. A. Oxetanes in drug discovery campaigns. J. Med. Chem. 66, 12697–12709 (2023). - DOI - PubMed - PMC
    1. Wuitschik, G. et al. Oxetanes in drug discovery: structural and synthetic insights. J. Med. Chem. 53, 3227–3246 (2010). - DOI - PubMed
    1. Wuitschik, G. et al. Oxetanes as promising modules in drug discovery. Angew. Chem. Int. Ed. 45, 7736–7739 (2006). - DOI
    1. Robinson, S. L., Christenson, J. K. & Wackett, L. P. Biosynthesis and chemical diversity of β-lactone natural products. Nat. Prod. Rep. 36, 458–475 (2019). - DOI - PubMed

LinkOut - more resources